Barclays Maintains Overweight on Elanco Animal Health, Raises Price Target to $22
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Balaji Prasad maintains an Overweight rating on Elanco Animal Health and raises the price target from $21 to $22.

September 23, 2024 | 3:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Barclays analyst Balaji Prasad has maintained an Overweight rating on Elanco Animal Health and increased the price target from $21 to $22, indicating a positive outlook on the stock.
The increase in price target from $21 to $22 by Barclays, along with maintaining an Overweight rating, suggests a positive sentiment towards Elanco Animal Health's stock. This is likely to have a positive short-term impact on the stock price as it reflects confidence from a reputable analyst.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100